Funders Constituent Committee (FCC)

The IRDiRC Funders Constituent Committee (FCC) brings together representatives from the public research funding members of IRDiRC, which include national and international governmental and non-profit funding bodies.
The FCC’s principal mission is to facilitate high-level coordination of funding initiatives to maximize the impact of rare diseases research projects by aligning strategies, avoiding unnecessary duplication, and identifying research funding gaps.
The FCC is currently developing a platform to coordinate and prioritize research funding efforts, identify mechanisms to enable international funding collaborations, and explore funding opportunities on the ethical, legal and social implications (ELSI) of rare diseases research.
In the long term, the FCC also intends to foster rare diseases research and to advocate for access to diagnosis and treatment in low- and middle-income countries, in keeping with IRDiRC’s Goals and Vision for 2017-2027

Marie-Christine Ouillade

AFM Board of Directors, AFM International Committee

Kristy Lidie

Deputy Director for Program Management

Daniel Scherman

Director

Domenica Taruscio

Director

???

awaiting appointment

David Pearce (Chair)

Sanford School of Medicine of the University of South Dakota

Susumu Kusunoki

Program Supervisor

Li Linkang

Executive President

Naveed Aziz

Vice President of Research and Innovation

Eva Bermejo-Sánchez

Director

Adam Hartman

Program Director

David Seo

Senior Vice President

Philippe Bouvet

Head of Biology & Health Department

Maria Pilar Aguar Fernandez

Director at the Directorate, People, Health and Society

 

Oleg Kvlividze

CEO

Tan Ee Shien

Head, Department of Genomic Medicine

Philip J. (PJ) Brooks

Director

Sonja van Weely

Scientific Officer, Sounding Board Group National Plan Rare Diseases

Maryna Polyakova

Translational Neuroscience WG Steward

Katherine Needleman

Director, Orphan Products Grants Program FDA/OOPD

Kristen Nowak

Director, Office of Population Health Genomics; Western Australia Department of Health

 

Jee young Kim

Director for Rare Disease Management, Department of Chronic Disease Prevention and Control

Jason Wan

Director, Mineralized Tissue Physiology Program
Integrative Biology and Infectious Diseases Branch

Raquel Peck

International Strategist, Rare As One Project

Ralph Schuster

Scientific Officer

Boya Yu

Project Manager

Melissa Parisi

Chief of Intellectual and Developmental Disabilities Branch

Zhang Shuyang

President

Anne-Cécile Desfaits

Associate Scientific Director

Stefano Benvenuti

Head of Public Affairs

Emmanuelle Genin

Director of Inserm Thematic Institute Genetics, Genomics & Bioinformatics

Faye H. Chen

Program Director, Rare Diseases and Integrated Physiology of Bone Program

Deborah Requesens

Director, JumpStart Program
Orphan Disease Center, University of Pennsylvania